Helptext
More News

Latest News

DateTimeSubject
6/4/20139:36 AMYield Life Science: Isofol Medical tecknar exklusivt avtal med Merck
5/24/201310:55 AMYield Life Science: Delårsrapport januari – mars 2013
5/20/201311:27 AMYield Life Science: Isofol Medical har genomfört fulltecknad nyemission

Graph with closing prices (blue curve) and volumes (red bars)

The graph has been adjusted for splits, reverse splits, issues and dividends
Graph for Yield Life Science B
 
Choose Date Horizon > 3 years 3 years 1 year 3 months 1 month 1 week Today

Company Information

Company NameYield Life Science AB
Company Idea

Yield Life Science utvecklar en portfölj av företag inom läkemedel och medicinteknik med potential för kraftig värdetillväxt.
CEOAnders HilmerssonChairm. of the BoardTommy Marklund
Phone0709-42 48 35Fax
Homepagehttp://www.yield.nuE-mailinfo(snabel-a)yield(punkt)nu

Instrument Information

Full NameYield Life Science BShort NameYILD B
No of shares12,319,335Ratio Value0.6 SEK
TypeShareISIN codeSE0001542325

Price Information

+/-(0.14)
%-3.42
Latest3.95
High3.95
Low3.95
Volume2,900
Turnover (SEK)11,455
Market Cap (Mkr)48.7

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
4:00 PMAVANDS3.951,900
3:40 PMAVAAVA3.951,000

Scheduled Reports

DateReport
2013-08-23Halvårsrapport
2013-11-22Delårsrapport tre

Latest Movies and hearings

DateDescription




  • Danderydsgatan 10
  • 114 86 Stockholm
  • Telefon: 08 - 545 038 00
  • Fax: 08 - 611 35 62
  • info(snabel-a)aktietorget(punkt)se